Novo Nordisk A/S is a leading global healthcare company based in Bagsvaerd, Denmark, specializing in the development and manufacturing of pharmaceuticals, particularly in the fields of diabetes care, obesity treatment, and hormone replacement therapy. With a strong focus on innovation and sustainability, Novo Nordisk leverages advanced biotechnology and scientific research to deliver effective solutions for chronic diseases. As a key player in the biopharmaceutical industry, the company is committed to improving patient outcomes while maintaining responsible business practices.